Literature DB >> 25875744

Gender impact on the correlations between subclinical thyroid dysfunction and hyperuricemia in Chinese.

Jianping Zhang1, Zhaowei Meng2, Qing Zhang3, Li Liu4, Kun Song5, Jian Tan6, Xue Li7, Qiang Jia8, Guizhi Zhang9, Yajing He10.   

Abstract

Overt hypothyroidism and hyperthyroidism can lead to hyperuricemia. However, few data are available regarding the association between subclinical thyroid dysfunction and hyperuricemia, especially from the perspective of gender impact. This study aimed to investigate the association between subclinical thyroid disorders and hyperuricemia with emphasized focuses on differences resulting from different gender. Eleven thousand four hundred forty-six healthy subjects (6870 male, 4576 female) were enrolled in this cross-sectional study, with exclusions of known thyroid, renal, hepatic, gastrointestinal, or oncological diseases. Clinical data including anthropometric measurements, thyroid function, uric acid, renal and liver function were collected. The associations between thyroid function and hyperuricemia of males and females were analyzed separately. Prevalence of hyperuricemia was substantially higher in male (23.17%) than that in female (9.11%). Serum uric acid was correlated well with various factors, especially with creatinine, whose coefficients were 0.283 and 0.386 for males and females. The significantly elevated risk for hyperuricemia was observed in mild hypothyroidism male participants with an odd ratio of 1.49 (1.10-2.02), whereas no statistical risk was found in female. No meaningful risk was found in mild hyperthyroidism participants. Estimated glomerular filtration rate was significantly depressed in both genders with mild hypothyroidism, while obviously increased in both genders with mild hyperthyroidism. For hyperuricemia, mild hypothyroidism is a risk factor in males while it is not in females. This difference could be caused by the protective effect of estrogen in females. Monitoring serum uric acid in subclinical hypothyroidism is more necessary in males.

Entities:  

Keywords:  Glomerular filtration rate; Hyperuricemia; Serum uric acid; Subclinical thyroid function disorders

Mesh:

Substances:

Year:  2015        PMID: 25875744     DOI: 10.1007/s10067-015-2867-4

Source DB:  PubMed          Journal:  Clin Rheumatol        ISSN: 0770-3198            Impact factor:   2.980


  38 in total

1.  Laboratory medicine practice guidelines: laboratory support for the diagnosis and monitoring of thyroid disease.

Authors:  L M Demers; C A Spencer
Journal:  Clin Endocrinol (Oxf)       Date:  2003-02       Impact factor: 3.478

2.  Some observations on 520 gouty patients.

Authors:  W C KUZELL; R W SCHAFFARZICK; W E NAUGLER; P KOETS; E A MANKLE; B BROWN; B CHAMPLIN
Journal:  J Chronic Dis       Date:  1955-12

3.  Gender and age impacts on the correlations between hyperuricemia and metabolic syndrome in Chinese.

Authors:  Qing Zhang; Shanshan Lou; Zhaowei Meng; Xiaojun Ren
Journal:  Clin Rheumatol       Date:  2010-12-22       Impact factor: 2.980

4.  Hyperuricemia and gout in thyroid endocrine disorders.

Authors:  N Giordano; C Santacroce; G Mattii; S Geraci; A Amendola; C Gennari
Journal:  Clin Exp Rheumatol       Date:  2001 Nov-Dec       Impact factor: 4.473

5.  Hyperuricemia in Saudi Arabia.

Authors:  A S Al-Arfaj
Journal:  Rheumatol Int       Date:  2001-02       Impact factor: 2.631

6.  Exacerbation of renal failure due to hypothyroidism in a patient with ischemic nephropathy.

Authors:  Y Makino; T Fujii; S Kuroda; T Inenaga; Y Kawano; S Takishita
Journal:  Nephron       Date:  2000-03       Impact factor: 2.847

7.  Serum uric acid concentration and thyroid-stimulating-hormone (TSH): results of screening for hyperuricaemia in 2359 consecutive patients with various degrees of thyroid dysfunction.

Authors:  W Raber; T Vukovich; H Vierhapper
Journal:  Wien Klin Wochenschr       Date:  1999-04-23       Impact factor: 1.704

Review 8.  Hyperuricemia and gout: new concepts in diagnosis and management.

Authors:  Paul P Doghramji; Robert L Wortmann
Journal:  Postgrad Med       Date:  2012-11       Impact factor: 3.840

9.  Relationship between lifestyle choices and hyperuricemia in Chinese men and women.

Authors:  Li Liu; Shanshan Lou; Ke Xu; Zhaowei Meng; Qing Zhang; Kun Song
Journal:  Clin Rheumatol       Date:  2012-11-07       Impact factor: 2.980

10.  Significance of high levels of serum malonyl dialdehyde (MDA) and ceruloplasmin (CP) in hyper- and hypothyroidism.

Authors:  L Dumitriu; R Bartoc; H Ursu; M Purice; V Ionescu
Journal:  Endocrinologie       Date:  1988 Jan-Mar
View more
  19 in total

1.  Gender impact on the correlations between Graves' hyperthyroidism and hyperuricemia in Chinese.

Authors:  Xuehui Liu; Jianping Zhang; Zhaowei Meng; Qiang Jia; Jian Tan; Guizhi Zhang; Xue Li; Na Liu; Tianpeng Hu; Pingping Zhou; Qing Zhang; Kun Song; Qiyu Jia
Journal:  Ir J Med Sci       Date:  2018-11-30       Impact factor: 1.568

2.  Low uric acid level increases the risk of infectious mononucleosis and this effect is more pronounced in women.

Authors:  Li Zhang; Pingping Zhou; Zhaowei Meng; Lu Gong; Chongjie Pang; Xue Li; Qiang Jia; Jian Tan; Na Liu; Tianpeng Hu; Qing Zhang; Qiyu Jia; Kun Song
Journal:  Mol Clin Oncol       Date:  2017-10-02

3.  Gender and Age-Specific Differences in the Association of Thyroid Function and Hyperuricemia in Chinese: A Cross-Sectional Study.

Authors:  Ming Yang; Suyan Cao
Journal:  Int J Endocrinol       Date:  2022-07-05       Impact factor: 2.803

4.  No associations exist between mean platelet volume or platelet distribution width and thyroid function in Chinese.

Authors:  Xiaojun Ren; Zhaowei Meng; Ming Liu; Mei Zhu; Qing He; Qing Zhang; Li Liu; Kun Song; Qiyu Jia; Qiang Jia; Xue Li; Jian Tan; Wei Zheng; Renfei Wang; Na Liu; Tianpeng Hu
Journal:  Medicine (Baltimore)       Date:  2016-10       Impact factor: 1.889

5.  The associations between leukocyte, erythrocyte or platelet, and metabolic syndrome in different genders of Chinese.

Authors:  Pingping Zhou; Zhaowei Meng; Ming Liu; Xiaojun Ren; Mei Zhu; Qing He; Qing Zhang; Li Liu; Kun Song; Qiang Jia; Jian Tan; Xue Li; Na Liu; Tianpeng Hu; Arun Upadhyaya
Journal:  Medicine (Baltimore)       Date:  2016-11       Impact factor: 1.889

6.  Gender and Age Impacts on the Association Between Thyroid Function and Metabolic Syndrome in Chinese.

Authors:  Zhaowei Meng; Ming Liu; Qing Zhang; Li Liu; Kun Song; Jian Tan; Qiang Jia; Guizhi Zhang; Renfei Wang; Yajing He; Xiaojun Ren; Mei Zhu; Qing He; Shen Wang; Xue Li; Tianpeng Hu; Na Liu; Arun Upadhyaya; Pingping Zhou; Jianping Zhang
Journal:  Medicine (Baltimore)       Date:  2015-12       Impact factor: 1.817

7.  Gender and Age Impact on the Association Between Thyroid-Stimulating Hormone and Serum Lipids.

Authors:  Zhaowei Meng; Ming Liu; Qing Zhang; Li Liu; Kun Song; Jian Tan; Qiang Jia; Guizhi Zhang; Renfei Wang; Yajing He; Xiaojun Ren; Mei Zhu; Qing He; Shen Wang; Xue Li; Wei Zheng; Tianpeng Hu; Na Liu; Arun Upadhyaya; Pingping Zhou; Jianping Zhang
Journal:  Medicine (Baltimore)       Date:  2015-12       Impact factor: 1.817

8.  Infectious mononucleosis and hepatic function.

Authors:  Li Zhang; Pingping Zhou; Zhaowei Meng; Chongjie Pang; Lu Gong; Qing Zhang; Qiyu Jia; Kun Song
Journal:  Exp Ther Med       Date:  2018-01-10       Impact factor: 2.447

9.  Associations of hyperuricemia and obesity with remission of nonalcoholic fatty liver disease among Chinese men: A retrospective cohort study.

Authors:  Chao Yang; Shujuan Yang; Chunhong Feng; Chuan Zhang; Weiwei Xu; Liyun Zhang; Yixin Yan; Jiaqi Deng; Okugbe Ebiotubo Ohore; Jing Li
Journal:  PLoS One       Date:  2018-02-07       Impact factor: 3.240

10.  Relationship between mean platelet volume and metabolic syndrome in Chinese patients.

Authors:  Fengxiao Zhao; Ziyu Yan; Zhaowei Meng; Xue Li; Ming Liu; Xiaojun Ren; Mei Zhu; Qing He; Qing Zhang; Kun Song; Qiyu Jia; Chunmei Zhang; Huiying Wang; Xiaoxia Liu; Xuemei Zhang; Xiaoran Wang; Zhengzhou Pan; Xiangxiang Liu; Wan Zhang
Journal:  Sci Rep       Date:  2018-10-01       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.